Navigation Links
Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever
Date:7/15/2009

istorical facts are forward-looking statements that are based on Cadence's current beliefs and expectations. Forward-looking statements include statements regarding the anticipated action date for the FDA to complete its review of the Acetavance NDA and the company's belief that this product candidate may fulfill an unmet medical need for a new class of intravenous medication to treat acute pain and fever in adults and children. The inclusion of forward-looking statements such as these should not be regarded as a representation by Cadence that any of its plans will be achieved. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in the company's business, including, without limitation: the possibility that the clinical trial and other data and information included in the NDA for Acetavance may be insufficient to support FDA approval or that adverse side effects associated with this product candidate may be more prevalent or severe than anticipated, which could prevent or significantly delay its regulatory approval; the potential that the FDA may require Cadence to perform additional studies, tests or other activities, or request additional information or clarification regarding information already provided, which could substantially delay the approval of the NDA; the possibility that the FDA's evaluations of the NDA or the company's clinical and manufacturing procedures and facilities may raise issues that must be resolved prior to obtaining final approval of the NDA; the risk that heightened scrutiny by the FDA over the new drug approval process and concerns regarding accidental and intentional overdoses of acetaminophen, primarily in the outpatient setting, may delay or prevent the approval of Acetavance, limit the indications for use or otherwise adversely impact the approved labeling for this product candidate; intense competition from existing and new products, which could diminish the com
'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Cowen & Companys 29th Annual Health Care Conference in Boston on March 16, 2009
5. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
6. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
8. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
11. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... third of women who are given information about the ... may not fully understand the risks involved, according to ... (BJC) , today (Friday). , In a survey of ... College London (UCL) found that 64 per cent felt ... the chance that screening will pick up cancers that ...
(Date:8/28/2014)... Recently, iFitDress.com, the popular online supplier of wedding ... new range of fashionable bridesmaid dresses . Along with ... items are offered with big discounts, from 15 to 65 ... September 16. , The company’s experienced workers never compromise ... why all its products are trendy and graceful. , “We ...
(Date:8/28/2014)... DE (PRWEB) August 28, 2014 Blood's Thicker ... gunplay, sex, money and family ties in the heart of ... no other – a story about how disrespect caused two ... limbs on many streets. , The Yayo Boyz and the ... news reporters speechless and local onlookers in a silent terror. ...
(Date:8/28/2014)... Worth, FL (PRWEB) August 28, 2014 ... National Recovery Month throughout September. This month will ... addiction treatment and mental health services. Along with ... Treatment Group is helping to spread the word ... began in 1989, honoring the work of treatment ...
(Date:8/28/2014)... 2014 Millennium Treatment Group recently announced a ... large, and Millennium Treatment Group is working to close it, ... need. , According to the National Survey on Drug ... Americans could have benefited from treatment for drug and/or substance ... This means that there is a large treatment gap in ...
Breaking Medicine News(10 mins):Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Fashionable Bridesmaid Dresses for Autumn 2014 from iFitDress.com 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Millennium Treatment Group Works to Close Treatment Gap 2
... WASHINGTON, Oct. 13 Speaker Nancy Pelosi, Congressman ... coalition of 20 youth organizations from 30 states for ... announce a key provision impacting young adults in health ... remain on the their parents, insurance through the age ...
... 13 DATATRAK International, Inc. (OTCQX: DATA), a technology ... the clinical trials industry, today announced its attendance at ... DATATRAK will be exhibiting in Booth 19 at the ... booth to see how DATATRAK ONE(TM) technology and services ...
... Finance Committee,s approval of an ambitious health reform plan marks ... care to tens of millions of people who lack it, ... face exorbitant charges, and begin to address the nation,s most ... costs. , The Congressional Budget Office has reported that the ...
... Yoest, President and CEO of Americans United for Life, made ... health care reform: , "The Senate Finance Committee ... care reform in reporting out a bill that does not ... fact, the Baucus bill explicitly includes abortion funding and coverage." ...
... released the following statement today from Executive Vice ... Committee,s approval today of historic health care reform ... of coordinated health benefits and quality focused coverage ... for chronically-ill and underserved Medicare recipients." ...
... 13 The 362,000-member National Taxpayers Union (NTU) ... to support the health care bill drafted by ... billions of dollars in damaging tax increases. This ... the already bloated federal budget while saddling middle ...
Cached Medicine News:Health News:Pelosi Announces Key Provision in Health Insurance Reform for Young Adults 2Health News:Pelosi Announces Key Provision in Health Insurance Reform for Young Adults 3Health News:Pelosi Announces Key Provision in Health Insurance Reform for Young Adults 4Health News:Pelosi Announces Key Provision in Health Insurance Reform for Young Adults 5Health News:Pelosi Announces Key Provision in Health Insurance Reform for Young Adults 6Health News:DATATRAK Exhibiting at the DIA's 3rd Annual Clinical Forum in Nice, France 2Health News:DATATRAK Exhibiting at the DIA's 3rd Annual Clinical Forum in Nice, France 3Health News:Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on The Senate Finance Committee's Health Reform Plan 2Health News:Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on The Senate Finance Committee's Health Reform Plan 3Health News:XLHealth Applauds Quality Focused Reforms in Senate Finance Committee Legislation 2Health News:Nation's Oldest Taxpayer Group Criticizes Committee Vote for Baucus Health Bill, Hidden Tax Increases 2
(Date:8/28/2014)... YORK, Aug. 28, 2014 Reportlinker.com announces ... in its catalogue: North America Aesthetic ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html ... Outlook to 2020 Summary GlobalData,s new ... Market Outlook to 2020", provides key market data ...
(Date:8/28/2014)... Aug. 28, 2014  Rigrodsky & Long, P.A.: , ... Inc. (NYSE: LCI )? , Did you purchase ... and July 16, 2014, inclusive? , Did you lose ... Do you want to discuss your rights? ... States Attorney, Timothy J. MacFall , announces that a complaint ...
(Date:8/28/2014)... NEW YORK , Aug. 28, ... a new market research report is ... Testing Laboratories, Safety and Compliance Services ... Metrics and Revenue Forecasts to 2021, ... http://www.reportlinker.com/p02347353/Testing-Laboratories-Safety-and-Compliance-Services-Industry-US--Analytics-Extensive-Financial-Benchmarks-Metrics-and-Revenue-Forecasts-to-2021-NAIC-541380 .html Testing ...
Breaking Medicine Technology:North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
The Welch Allyn 125 BIO is designed to achieve precise binocular viewing and stereopsis easier than ever before. Its observation paths can be adjusted from 48 mm to 74 mm to handle the widest and nar...
Welch Allyn quality in a convenient pocket size. The PocketScope fits into your pocket! Easy to use, lightweight, and perfect for general and specialist use. Take your PocketScope with you everywhere...
Medicine Products: